At-Home Genital Nerve Stimulation for SCI Bowel

This study is exploring if a treatment called genital nerve stimulation (GNS) can help people with spinal cord injuries (SCI) manage their bowel function. GNS uses a device with small pads placed on the skin near the genitals to deliver electrical stimulation. Researchers want to see if this daily at-home treatment can reduce bowel accidents. You might be able to join if you are 18 or older, have a spinal cord injury, and meet other specific health criteria. The main goal is to see if using GNS every day for 6 weeks is practical and safe.

Study design
This study plans to enroll 12 participants. It will compare a target stimulation level to a placebo stimulation level.
What's involved
You would use electrical stimulation on the skin in the pelvic area for 6-8 hours each day for 4 weeks at home. You will also visit the research center 3 times for exams and questions, and keep a daily diary.
Compensation
Not stated in the trial record.
Follow-up
The primary goal is measured from baseline to the end of 6 weeks.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06836739

At-Home Genital Nerve Stimulation for SCI Bowel

Recruiting
NAAges 18+InterventionalTreatment
MetroHealth Medical Center
~12 participants
Updated 2026-07-28 on ClinicalTrials.gov
What's tested:Genital nerve stimulation

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
The primary endpoint will be the feasibility of daily application of GNS as an intervention for NBD.
Measured over From baseline to the end of 6 weeks
+2 more outcomes measured
Spinal Cord Injury
1 sites across 1 states
Ohio1
  • Kim Anderson, PhD · PRINCIPAL_INVESTIGATOR · MetroHealth System, Ohio

Opens a ready-to-send draft in your own email app — review before sending.

  • The primary endpoint will be the feasibility of daily application of GNS as an intervention for NBD.From baseline to the end of 6 weeks

    The 1st feasibility measure bench mark will be the proportion of enrolled who complete the full stimulation protocol.

  • The primary endpoint will be the feasibility of daily application of GNS as an intervention for NBD.From baseline to the end of 6 weeks

    The 2nd feasibility measure bench mark will be the number of occurrences of unblinding.

  • The primary endpoint will be the feasibility of daily application of GNS as an intervention for NBD.From baseline to the end of 6 weeks

    The 3rd feasibility measure bench mark will be the retention rate.